Cyproheptadine Hydrochloride
NDC 16571-805, Cyproheptadine Hydrochloride, tablet, from Rising Pharma Holdings, Inc..
- Product NDC
- 16571-805
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207555
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16571-805 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CYPROHEPTADINE HYDROCHLORIDE4 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16571-805-01 | 16571080501 | 100 TABLET in 1 BOTTLE (16571-805-01) |
| 16571-805-10 | 16571080510 | 1000 TABLET in 1 BOTTLE (16571-805-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c5e9e983-d0d2-4f87-beae-0d853ca43983NADAC price for package 16571080501
GET /v1/drugs/nadac/16571080501NADAC price for package 16571080510
GET /v1/drugs/nadac/16571080510
Use it
Look up 16571-805 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16571-805 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16571-805. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.